Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
2.260
-0.200 (-8.13%)
At close: May 22, 2026, 4:00 PM EDT
2.230
-0.030 (-1.33%)
After-hours: May 22, 2026, 7:56 PM EDT

Clearmind Medicine Balance Sheet

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Cash & Equivalents
9.263.926.575.430.133.71
Short-Term Investments
1.091.660.290.090.19-
Cash & Short-Term Investments
10.355.596.865.510.323.71
Cash Growth
74.90%-18.62%24.47%1609.58%-91.32%1400.73%
Other Receivables
0.440.320.180.240.10.13
Total Trade Receivables
0.440.320.180.240.10.13
Other Current Assets
0.240.040.040.040.010.13
Total Current Assets
11.025.957.095.790.433.97
Net Property, Plant & Equipment
0.010.020.0500.050.02
Other Intangible Assets
0.090.10.110.120.130.16
Other Long-Term Assets
0.020.020.010.040.210.02
Total Assets
11.146.087.265.950.834.17
Accounts Payable
1.140.740.580.661.60.29
Short-Term Debt
-1.76----
Current Portion of Leases
0.010.020.04-0.04-
Other Current Liabilities
1.762.373.524.310.29-
Total Current Liabilities
2.914.894.134.971.930.29
Long-Term Leases
--0.02---
Total Long-Term Liabilities
--0.02---
Total Liabilities
2.914.894.154.971.930.29
Common Stock
35.9526.424.1717.136.716.38
Additional Paid-in Capital
4.052.692.982.642.361.08
Accumulated Other Comprehensive Income
-0.02-0.02-0.02-0.02-0.02-
Retained Earnings
-31.73-27.88-24.02-18.77-10.15-3.58
Shareholders' Equity
8.241.193.110.98-1.113.88
Total Liabilities & Equity
11.146.087.265.950.834.17
Total Debt
0.011.780.0500.040
Net Cash (Debt)
10.343.816.815.510.283.71
Net Cash Growth
171.61%-44.10%23.51%1840.56%-92.35%1400.73%
Net Cash Per Share
265.39299.51878.6810892.632622.6948064.06
Book Value
8.241.193.110.98-1.113.88
Book Value Per Share
211.4793.84400.961942.85-10208.8050179.00
Tangible Book Value
8.141.130.86-1.243.72
Tangible Book Value Per Share
209.0486.17386.981707.16-11411.2048109.50
Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q